ArticleRSC advances2025
Catalytic reduction of aldehydic and nitro groups of nitro-benzaldehyde derivatives by silver nanoparticle-containing smart alginate-poly(
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Catalytic and photocatalytic reduction/degradation of methyl red dye by metal nanoparticles, metal oxides, and their composites: a critical review.RSC advances · 2026Review
- Advances in metal nanoparticle-based catalysts for nitroarene reduction: from mechanistic understanding to sustainable design.RSC advances · 2026Review
- Sustainable green-synthesized hematite nanocatalysts and their efficient reduction of aromatic nitro pollutants.RSC advances · 2026Article
- Catalytic reduction/degradation of methyl orange by metal nanoparticle containing systems: a critical review.RSC advances · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aromatic compounds containing aldehyde and nitro groups are very toxic to human health. Moreover, complete degradation of these compounds is not possible. Therefore, these compounds are converted into less toxic but more useful hydroxy-methyl aniline (HMA) derivatives. This conversion is performed using a suitable catalyst and a reducing agent. Therefore, alginate-poly(
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.